The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2023
Filed:
Mar. 09, 2021
Applicants:
The United States of America, As Represented BY the Secretary, Dept of Health and Human Services, Bethesda, MD (US);
Novo Nordisk A/s, Bagsværd, DE;
Inventors:
Alan Thomas Remaley, Bethesda, MD (US);
Soumitra Shanker Ghosh, San Diego, CA (US);
Madhav N. Devalaraja, Acton, MA (US);
Chih-Hung Lo, Rockville, MD (US);
Denis O. Sviridov, Rockville, MD (US);
Anna Wolska, Washington, DC (US);
Assignees:
Novo Nordisk Inc., Bagsvaerd, DK;
United State of America, As Represented by the Secretary, Dept. of Health and Human Services, Bagsvaerd, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); C07K 14/775 (2006.01); A61K 9/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/775 (2013.01); A61K 38/1709 (2013.01); A61K 38/1722 (2013.01); A61K 9/0019 (2013.01); A61K 38/00 (2013.01); C07K 2317/53 (2013.01); C07K 2319/21 (2013.01); C07K 2319/41 (2013.01); C07K 2319/42 (2013.01);
Abstract
The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.